Grand Rounds April 26, 2024: Waiver or Alteration of Informed Consent for Minimal Risk Clinical Investigations – FDA Regulation Development and Research Landscape (Lauren Milner, PhD; Jonathan Casey, MD, MSCI; Matthew Semler, MD, MSCI)

Speakers: Lauren Milner, PhD Office of Clinical Policy US Food and Drug Administration  (FDA) Jonathan Casey, M.D., MSCI Assistant Professor, Division of Pulmonary and Critical Care Medicine Vanderbilt University Medical […]